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During embryonic development and adult life, the cadherin super-
family of cell adhesion molecules is known to be involved in many
processes including cell segregation, proliferation, differentia-
tion, and invasive behaviour (Takeichi, 1993). In human cancer,
E-cadherin, which is an epithelial cell adhesion molecule, has been
recognized as a powerful invasion-suppressor. It has been reported
that the function of E-cadherin in zonula adherens junctions is
impaired in many kinds of epithelial cancers (Shiozaki et al, 1996;
Hirohashi, 1998).
Endometrial cancer, one type of epithelial cancer, is a unique
epithelial cancerous state with varying levels of differentiation. In
general, the oestrogen and progesterone receptors are expressed in
many cases of well differentiated endometrioid adenocarcinomas,
but are lacking in poorly differentiated endometrioid adenocarci-
nomas (Creasman, 1993). In terms of clinicopathological proper-
ties, poorly differentiated adenocarcinomas are characterized by
deep myometrial invasion, high metastatic ability and a poor clin-
ical prognosis (Kauppila et al, 1982; Creasman, 1993). In contrast,
well differentiated adenocarcinomas of the endometrium have
a less invasive ability, less metastatic potential, but a more
favourable prognosis (Kauppila et al, 1982; Creasman, 1993).
Thus, there seem to be distinct differences in cancer cells between
well and poorly differentiated adenocarcinomas.
E-cadherin is a homophilic cell adhesion molecule, which
depends on the presence of Ca2+ ions. It is a transmembrane
protein with five tandemly repeated extracellular domains and a
cytoplasmic domain that connects the actin cytoskeleton through a
complex with a-, b-, and g-catenins. E-cadherin and cytoskeletal
molecules play a crucial role in cellular morphogenesis and cell
regulation, including cell shape and function (Takeichi 1993;
Aberle et al, 1996; Drubin and Nelson 1996; Gumbiner, 1996).
Protein p120CAS has also been defined as a member of the
cadherin-based cell–cell adhesion complex, containing a series of
42 amino acid armadillo repeats, and binds directly to E-cadherin
(Daniel and Reynolds, 1995). IQGAP1, as a candidate effector for
the Rho family of GTPases, including Rac1 and Cdc42, can also
bind b-catenin and E-cadherin (Kuroda et al, 1998). Therefore,
E-cadherin function is apparently influenced by the binding of
a-catenin, b-catenin, g-catenin, p120CAS, or IQGAP1 in different
cell regulating processes.
To investigate the alterations of E-cadherin associated with
cytoplasmic molecules among subtypes of endometrial cancers
with varying differentiation, we examined the localization and
expression of E-cadherin and cytoplasmic molecules, using
surgical specimens from a normal endometrium and malignant
endometrial tissues including well and poorly differentiated
adenocarcinomas. We found that the localization of a-catenin and
IQGAP1 were disturbed in a different manner in well and poorly
differentiated adenocarcinomas, compared to the findings for
the normal endometrium. Comparing extracted proteins at cell
adhesive sites from well differentiated adenocarcinomas, we
found remarkable differences in protein expression and protein
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modification of E-cadherin and cytoplasmic molecules in Triton-
insoluble fraction, compared to that of poorly differentiated adeno-
carcinomas. These results suggested that changes in E-cadherin
associated with cytoplasmic molecules may be involved in the
impairment of E-cadherin function in endometrial cancers with
varying degrees of differentiation.
MATERIALS AND METHODS
Human tissues
Fresh specimens of endometrioid adenocarcinomas (20 well
differentiated and 10 poorly differentiated adenocarcinomas) were
obtained at surgery from 30 Japanese patients with endometrial
carcinomas. The clinical features of the two types of endometrial
cancers are summarized in Table 1. Normal endometrial tissue
specimens were also obtained at surgery for benign disease from 4
Japanese patients in the follicular phase of the menstrual cycle.
After dissection, some tissue specimens were embedded in OCT
compound (Miles Laboratories, Eilhart, IN), and immediately
snap-frozen in liquid nitrogen. Frozen sections were cut on a
cryostat to a thickness of 4 mm, mounted on poly-L-lysine-2 coated
slides, and either used immediately or stored at –80°C
until needed, in order to assess the co-localization of E-cadherin
and its associated cytoplasmic molecules using immuno-
fluorescent analysis. The remaining tissue specimens dissected
from the same patient were directly frozen in liquid nitrogen
and also stored at –80°C, after which proteins were extracted, in
order to examine the protein expression of E-cadherin and its
associated cytoplasmic molecules using western blotting and tyro-
sine phosphorylation of b-catenin and p120CAS using immuno-
precipitation.
Immunostaining
Sections for immunostaining were fixed in PBS (phosphate-
buffered saline) with 4% paraformaldehyde and 5% sucrose for one
hour at room temperature, washed three times with PBS, and perme-
abilized for 5 min with 0.4% Triton X-100 in PBS. The sections
were next washed three times with PBS, and blocked for 30 min
with 5% goat serum in PBS. These sections were incubated
overnight with primary antibodies at 4°C. The next day the sections
were washed three times for 15 min each, incubated with secondary
antibodies conjugated with fluorescein and Texas-red for 1 hour
at room temperature, and then washed three times with
PBS for 15 min each time. As for double staining in the use of 
pan-c1168adherin antibody, a solution of 150 mM NaCl, 50 mM
Tris (pH 7.4), and 10 mM CaCl2 was used instead of PBS. The
sections were analysed by immunofluorescence microscopy, as
described, using a Nikon HFX-II microscope equipped for fluor-
escein and Texas-red (Miyamoto et al, 1995). To acquire the
assessment for distinct co-localization among E-cadherin and its
associated cytoplasmic molecules, immunofluorescent signals in the
cells were first magnified on a 21-inch display, overlaid, and exam-
ined using a Carl-Zweiss FISH system. For double staining, co-
localization was calculated as the ratio A/B, where A equals the
number of cells with an accumulation of yellow signals appearing as
an immunofluorescent overlap at cell adhesive sites and B equals the
number of cells with an accumulation of red signals at the cell adhe-
sive sites. For each section, 100 cells were scored, and the scoring
was repeated three times for the different fields. The sum of all three
experiments was calculated. Immunostaining was repeated on at
least three sections from each sample and the average percentage for
the A/B ratio was recorded as the co-localization scoring. In each
case, one additional section was stained with hematoxylin and eosin
for verifying the presence of cancer cells and confirming the histo-
logical grading.
Immunological reagents
Antibodies against adhesion and cytoplasmic molecules, including
E-cadherin,  a-catenin,  b-catenin,  g-catenin and p120CAS were
purchased from Transduction Laboratories (Lexington, KY, USA).
A polyclonal antibody against IQGAP1 was used. For the double
staining of E-cadherin with other molecules, we used a pan-
cadherin antibody obtained from Sigma Chemical Company
(St. Louis, MO, USA). Fluorescein and Texas-red labelled
secondary antibodies were obtained from BioSource International
(Camarillo, CA, USA) and Molecular Probes (Eugene, OR, USA),
respectively. Monoclonal antibody against phosphotyrosine was
obtained from Upstate Biotechnology (Lake Placid, NY, USA).
Sheep anti-mouse IgG and rabbit IgG conjugated with peroxidase
(Amersham Corp, Arlington Heights, IL, USA) were used as
secondary antibodies for Western immunoblotting.
Extraction of Triton-soluble and Triton-insoluble
proteins
To compare the protein expression of E-cadherin and its associated
cytoplasmic molecules between Triton-soluble and Triton-
insoluble components, specimens (approximately 5 ´ 5 ´ 5 mm)
were solubilized in 3 ml modified CSK extraction buffer (0.5%
Triton X-100, 50 mM NaCl, 300 mM sucrose, 3 mM MgCl2,
0.2 U/ml aprotinin, 2 mg/ml leupeptin, 1 mg/ml pepstatin A, 2 mM
PMSF (phenylmethylsulphonyl fluoride), 10 mM Pipes (1,4 piper-
azinediethanesulphonic acid) pH 6.2, 1 mM sodium orthovana-
date, 50 mM sodium fluoride, 40 mM sodium pyrophosphate) in a
sonicator for 10 sec at 4°C, using a micro-ultrasonic cell disruptor
(Kontes). After centrifugation for 1 hour at 4°C, the supernatant
was utilized as the Triton-soluble fraction. Pellets were re-
extracted, solved completely with 3 ml RIPA containing 1% Triton
X-100, 1% sodium deoxycholate, 0.1% SDS (sodium dodecyl
sulphate), 150 mM NaCl, 50 mM Tris, pH 8.0, 0.2 U/ml aprotinin,
2 mg/ml leupeptin, 1 mg/ml pepstatin A, 2 mM PMSF, 1 mM
sodium orthovanadate, 50 mM sodium fluoride, 40 mM sodium
pyrophosphate, and then the extracted protein was used as the
Table 1 Clinical features in endometrial cancers
G1 (N = 20) G3 (N = 10)
Ages 54.2 ± 12.3 (30–72) 51.3 ± 13.2 (30–66)
Stages I 14 5
II 4 3
III 2 2
IV 0 0
Myometrial None 11 1
Invasion ≤ 1/2 9 2
> 1/2 0 7
Lymph Node  1 7
Involvement
G1: Well differentiated adenocarcinomas, G3: Poorly differentiated
adenocarcinomas.1170 S Miyamoto et al
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Triton-insoluble components (Miyamoto et al, 1995). The protein
concentrations of these two fractions were determined using a
modification of the method of Bradford (Pierce Chemical,
Rockford, IL, USA) (Bradford, 1976). The extracted protein ratios
(mean ± standard deviation) between the Triton-insoluble com-
ponents and the Triton-soluble components (Triton-insoluble
components/Triton-soluble components) were 0.64 ± 0.21 (normal
endometrial tissues), 0.60 ± 0.22 (well differentiated adenocarci-
nomas), and 0.65 ± 0.18 (poorly differentiated adenocarcinomas).
Immunoblotting and immunoprecipitation
An equivalent amount (30 mg for the Triton-insoluble compon-
ents and 70 mg for the Triton-soluble components) of each fraction
was subjected to SDS-PAGE and was analysed by Western im-
munoblotting. To examine the tyrosine phosphorylation of
b-catenin and p120CAS, immunoprecipitation was performed for the
protein (1000 mg) of each fraction, by using 5 mg anti-b-catenin and 5
mg anti-p120CAS antibodies, and the precipitated samples were
applied to SDS-PAGE and analysed by Western immunoblotting,
using an anti-phosphotyrosine antibody, and then the same immunob-
lot was re-analysed with the appropriate antibodies.
Statistical analysis
Comparisons of co-localization scorings among the three groups
were made using the Bonfferoni’s t-test. P values < 0.05 were
interpreted as indicating a significant difference.
RESULTS
Co-localization of E-cadherin and its associated
cytoplasmic molecules including a-catenin, b-catenin,
g-catenin, p120CAS, and IQGAP1
To investigate the co-localization between E-cadherin and its
associated cytoplasmic molecules, double immunostaining for
E-cadherin and IQGAP1, the three catenins, or p120CAS were
examined in normal endometrium, well, and poorly differentiated
adenocarcinomas. E-cadherin and its associated cytoplasmic mole-
cules were expressed only in normal endometrial cells, endome-
trial cancer cells, and endothelial cells of vascular vessels within
the tissue specimens. E-cadherin and IQGAP1 co-localized at cell
adhesive sites as well as at the regions bordering stromal tissues
in normal endometrium (Fig. 1A,B,C). In well differentiated
adenocarcinomas, immunofluorescent signals for E-cadherin were
observed along the zonula adherens junctions as a thinly broken
line or a diffuse band, inside as well as outside the cancer tubules
(Fig. 1D). The immunofluorescent signals for IQGAP1 revealed
diffusely distributed staining in cancer cells inside and outside
cancer tubules, and the localization of IQGAP1 did not coincide
with that of E-cadherin (Fig. 1E, F). In poorly differentiated
adenocarcinomas, E-cadherin or IQGAP1 was stained in part
as large aggregates at zonula adherens junctions (Fig. 1G, H).
Co-localization between E-cadherin and IQGAP1 was in part
seen as abnormally clumped immunofluorescent signals along the
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Figure 1 The Distribution of E-cadherin and IQGAP1 in normal endometrium (N), well differentiated adenocarcinomas (G1), and poorly differentiated
adenocarcinomas (G3). The localization of E-cadherin (green) or IQGAP1 (red) was determined using fluorescein or Texas-red, and immunofluorescence
overlap of E-cadherin and IQGAP1 was observed as a yellow signal (*). The localization of E-cadherin and IQGAP1 proteins was observed at the zonula
adherens junctions in normal endometrium (A and B) and well differentiated adenocarcinomas (D and E). In poorly differentiated adenocarcinomas, the
immunostaining signals for E-cadherin and IQGAP1 revealed large aggregates along the cell boundary (G and H). Co-localization of E-cadherin and IQGAP1 is
shown for each of the three groups (C, F and I). Each inset shows a higher-magnification view. Bar, 20 mmE-cadherin dysfunction and tumour differentiation 1171
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zonula adherens (Fig. 1I). On the other hand, E-cadherin and
b-catenin accumulated linearly and completely co-localized at the
zonula adherens junctions and the borders of normal endometrium
(Fig. 2A,B,C). In well differentiated adenocarcinomas, immuno-
staining signals for b-catenin or E-cadherin were seen as a thinly
broken line or a diffuse band along cell boundaries, and the
localization of b-catenin coincided almost perfectly with that of
E-cadherin (Fig. 2D,E,F). In poorly differentiated adenocarci-
nomas, accumulations of b-catenin and E-cadherin were detected,
in part, at the cell boundaries, as clumped, aggregated spots
(Fig. 2G,H). However, the distribution of E-cadherin was not
always consistent with that of b-catenin (Fig. 2I).
To gain more insight into the distribution of each cytoplasmic
molecule mediated by E-cadherin, we compared the localization
of a-catenin, b-catenin, g-catenin and p120CAS to IQGAP1 in
these two types of endometrial cancers. In well differentiated
adenocarcinomas, the signals for a-catenin as well as IQGAP1
were diffusely distributed, without any co-localization inside the
cells (Fig. 3A,B,C). In poorly differentiated adenocarcinomas,
a-catenin and IQGAP1 were in part localized along cell bound-
aries, but immunofluorescent signals for a-catenin did not
coincide with those of IQGAP1 at all (Fig. 3D,E,F). No
morphological difference between IQGAP1 positive and a-catenin
positive parts was found in the sections using haematoxylin and
eosin staining. The co-localization scorings of the three catenins or
p120CAS with E-cadherin, and E-cadherin, the three catenins,
or p120CAS with IQGAP1 are shown in Table 2. E-cadherin and
IQGAP1 were usually detected in the basolateral regions of the
cells in normal endometrium. The three catenins and p120CAS
were sometimes localized in the basolateral regions only in normal
endometrium. In all 4 cases of normal endometrium, the immuno-
fluorescent signals for a-catenin, b-catenin, g-catenin, p120CAS,
or IQGAP1 revealed a linear accumulation at the cell boundaries,
and all the E-cadherin associated with cytoplasmic molecules were
positively co-localized with E-cadherin. In all 20 cases of well
differentiated adenocarcinomas, the immunofluorescent signals
for  b-catenin, g-catenin or p120CAS indicated thinly broken lines
or diffuse bands, and a-catenin or IQGAP1 was diffusely distrib-
uted inside the cells. The co-localization scorings of b-catenin,
g-catenin, or p120CAS with E-cadherin were almost the same as
those in patients with normal endometrium, whereas the co-
localization scorings of a-catenin with E-cadherin and E-cadherin,
the three catenins, or p120CAS with IQGAP1 significantly
decreased, compared with the scorings in patients with normal
endometrium and poorly differentiated adenocarcinoma because
of a diffuse distribution of a-catenin and IQGAP1. In all the 10
cases of poorly differentiated adenocarcinomas, a-catenin,  b-
catenin,  g-catenin, p120CAS, or IQGAP1 partly accumulated
along the zonula adherens junctions as clumped aggregates, and
each co-localization scoring of the three catenins or p120CAS
with E-cadherin significantly decreased, compared with those in
normal endometrium, although only the co-localization scoring of
E-cadherin with IQGAP1 was almost the same percentage as those
in patients with normal endometrium. In poorly differentiated
adenocarcinoma, the three catenins and p120CAS were distinctly
expressed in some of the cancer cells, which had no expression of
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Figure 2 The Distribution of E-cadherin and b-catenin in normal endometrium (N), well differentiated adenocarcinomas (G1), and poorly differentiated
adenocarcinomas (G3). The localization of b-catenin (green) or E-cadherin (red) was determined using fluorescein or Texas-red fluorescence, and
immunofluorescence overlap of b-catenin and IQGAP1 was observed as a yellow signal (*). b-catenin and E-cadherin proteins were observed at the zonula
adherens junctions in normal endometrium (A and B), well differentiated adenocarcinomas (D and E), and poorly differentiated adenocarcinomas (G and H).
Co-localization of b-catenin and E-cadherin is shown for each of the three groups (C, F and I). Each inset shows a higher-magnification view. Bar, 20 mmIQGAP1 and little expression of the three catenins, and p120CAS
was observed in the other cells in which the expression of
IQGAP1 was apparently detected. However, there were no signifi-
cant differences in morphological appearance between IQGAP1
positive parts and the 3 catenins or p12CAS positive parts using
haematoxylin and eosin staining.
In each of the 4 cases of normal endometrium in the secretory
phase or in menopause, E-cadherin and its associated cytoplasmic
molecules were co-localized as a clear line at the zonula adherens
junctions, just like a normal endometrium in the follicular phase.
In both types of endometrial cancers, the immunofluorescent
signals for b-catenin were partly detected in the cytoplasm, but no
distinct accumulation of b-catenin in the nucleus was found in the
normal endometrium or endometrial cancers.
Protein expression of E-cadherin and its associated
cytoplasmic molecules including a-catenin, b-catenin,
g-catenin, p120CAS, and IQGAP1
To determine if E-cadherin or its associated cytoplasmic mole-
cules decreased or were lost at cell adhesive sites, we extracted the
protein as Triton-soluble or Triton-insoluble fraction, and
compared the expression of E-cadherin and cytoplasmic mole-
cules in each fraction of all the tissues. Using the protein in Triton-
insoluble fraction, the expression of E-cadherin was not detec-
ted in 3 of 5 cases with well differentiated adenocarcinomas,
whereas E-cadherin was clearly expressed in all 4 cases with
normal endometrium and the 5 cases with poorly differentiated
adenocarcinomas (Fig. 4). The expression of b-catenin in Triton-
insoluble fraction was found in all 4 cases with normal
1172 S Miyamoto et al
British Journal of Cancer (2000) 83(9), 1168–1175 © 2000 Cancer Research Campaign
a-catenin
IQGAP1
*
G3
A D
E
C
B
F
G1
Figure 3 The distribution of a-catenin and IQGAP1 in well differentiated
adenocarcinomas (G1) and poorly differentiated adenocarcinomas (G3). The
localization of a-catenin (green) or IQGAP1 (red) was determined using the
fluorescein or Texas-red fluorescence, and immunofluorescence overlap of
a-catenin and IQGAP1 was observed as a yellow signal (*). The diffuse
expression of a-catenin (A) and IQGAP1 (B) was evident in well
differentiated adenocarcinomas. As large aggregates, a-catenin and IQGAP1
proteins were observed in poorly differentiated adenocarcinomas
(D and E). No immunofluorescence overlap of a-catenin and IQGAP1 was
noted in the well differentiated adenocarcinomas (C) or in poorly
differentiated adenocarcinomas (F). Each inset shows a higher-magnification
view. Bar, 20 mm
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Figure 4 The expression of E-cadherin and its associated cytoplasmic
molecules in proteins of the triton-insoluble (I) and the triton-soluble fraction
(S) extracted from normal endometrium (N), well differentiated
adenocarcinomas (G1), and poorly differentiated adenocarcinomas (G3).
In Triton-insoluble fraction (I), E-cadherin and b-catenin were expressed in
normal endometrium, well differentiated adenocarcinomas, and poorly
differentiated adenocarcinomas. The expression of a-catenin or IQGAP1 in
the two fractions of triton-insoluble (I) and triton-soluble (S) components was
detected in normal endometrium, well differentiated adenocarcinomas, and
poorly differentiated adenocarcinomas. Protein extraction was independently
performed at least twice for all samples. Immunoblotting was done three
times for each extracted protein. The results were consistent in each
experiment
Table 2 Co-localization of E-cadherin and its associated cytoplasmic molecules
Co-localization scoring (mean ± S.D.)
E-Cadherin (P) IQGAP1 (P)
N G1 G3 N G1 G3
(N = 4) (N = 20) (N = 10) (N = 4) (N = 20) (N = 10)
E-cadherin (M) 95.2 ± 4.5 96.2 ± 4.5 95.4 ± 7.5 94.2 ± 3.8 15.9 ± 8.2a 80.2 ± 14.6
a-catenin(M) 88.2 ± 4.2 15.2 ± 9.5a 64.5 ± 6.5a 89.5 ± 5.4 5.2 ± 7.2a 16.2 ± 8.2a
b-catenin (M) 89.2 + 4.3 82.3 ± 7.0 62.5 ± 4.8a 96.2 ± 5.2 17.2 ± 5.2a 14.3 ± 8.9a
g-catenin (M) 87.5 ± 6.2 81.3 ± 8.2 59.2 ± 4.0a 94.2 ± 3.2 18.2 ± 5.2a 15.2 ± 9.1a
p120CAS (M) 90.5 ± 4.2 83.2 ± 7.4 68.2 ± 7.0a 92.2 ± 4.2 20.2 ± 4.2a 18.2 ± 5.9a
Table shows the results for double staining, using monoclonal antibodies (M) and polyclonal antibodies (P). aSignificant decrease of 
co-Iocalization scoring, compared to patients with normal endometrium. N: Normal endometrium, G1: Well differentiated
adenocarcinomas, G3: Poorly differentiated adenocarcinomas.E-cadherin dysfunction and tumour differentiation 1173
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endometrium, one of 5 cases with well differentiated adenocarci-
nomas, and in 4 of 5 cases with poorly differentiated adenocarci-
nomas. To confirm the loss of other cytoplasmic molecules
associated with E-cadherin, we examined the expression of a-
catenin and IQGAP1 in the two fractions. In the Triton-insoluble
fraction, a-catenin and IQGAP1 were clearly expressed in all 4
cases with normal endometrium and all 5 cases with poorly differ-
entiated adenocarcinomas, but no expression of a-catenin or
IQGAP1 was noted in any of the 5 cases with well differentiated
adenocarcinomas. However, a-catenin and IQGAP1 in the Triton-
soluble fraction were distinctly expressed in all tissue specimens
(Fig. 4). Table 3 summarizes the expression of E-cadherin and its
associated cytoplasmic molecules in each fraction among normal
endometrium, well and poorly differentiated adenocarcinomas. In
all 4 cases with normal endometrium, E-cadherin, 3 catenins,
p120CAS, and IQGAP1 were distinctly expressed in both frac-
tions. Among the 20 cases with well differentiated adenocarci-
nomas, the expression of E-cadherin was found in 5 cases, and in a
few cases, the expression of b-catenin, g-catenin, or p120CAS was
noted in Triton-insoluble fraction. However, the expression of a-
catenin or IQGAP1 in Triton-insoluble fraction was detected in
none of the 20 cases. In all 10 cases of poorly differentiated
adenocarcinomas, the expression of E-cadherin, a-catenin, 
g-catenin, p120CAS, or IQGAP1 was distinctly found, and the
expression of b-catenin was detected in 9 of 10 cases in Triton-
insoluble fraction. Each expression of E-cadherin, the three
catenins, p120CAS, or IQGAP1 was distinctly found in Triton-
soluble fraction extracted from all the cases including the 4 with
normal endometrium, 20 cases with well differentiated adenocar-
cinomas, and 10 cases with poorly differentiated adenocarci-
nomas.
Protein modification of b-catenin and p120CAS in each
fraction
To test the protein modification of cytoplasmic molecules, we
examined tyrosine-phosphorylation of b-catenin and p120CAS in
each fraction. In Triton-insoluble fraction, tyrosine residues of
b-catenin were clearly phosphorylated in all 4 cases with normal
endometrium and all 5 cases with poorly differentiated adeno-
carcinomas, but not in 3 of 5 cases with well differentiated 
adencarcinomas (Fig. 5). The tyrosine-phosphorylation of p120-
CAS in Triton-insoluble fraction was detected in all 4 cases with
normal endometrium, 4 of 5 cases with well differentiated adeno-
carcinomas, and 4 of 5 cases with poorly differentiated adenocar-
cinomas (Fig. 5). The results of all cases are summarized in Table
3. Using the protein in Triton-insoluble fraction, tyrosine-
phosphorylation of b-catenin or p120CAS was found in all 4
cases with normal endometrium, and in 20 cases with well 
diffentiated adenocarcinomas, 4 cases had clear tyrosine-
phosphorylation of b-catenin, and 17 cases also indicated tyro-
sine-phosphorylation of P120CAS. In Triton-insoluble fraction,
b-catenin was strongly tyrosine-phosphorylated in all 10 cases
with poorly differentiated adenocarcinomas, whereas 9 of 10
cases indicated tyrosine-phosphorylation of p120CAS. In this
study, the amount of b-catenin immunoprecipitated in Figure 5
was not correlated with those in Figure 4 among the patients with
well differentiated adenocarcinoma. Figure 4 shows that the
amount of b-catenin included in Triton-insoluble fraction signifi-
cantly decreased in patients with well differentiated adenocarci-
noma, and Figure 5 shows that the tyrosine phosphorylated form
of b-catenin was little detected in precipitating the same amount
of b-catenin included in Triton-insoluble fraction among these
patients. Thus, these results indicated that the amount of b-
catenin in Triton-insoluble fraction markedly decreased,
compared to those in patients with normal endometrium and that
most of the b-catenin included in Triton-insoluble fraction was of
a tyrosine-unphosphorylated form in patients with well differenti-
ated adenocarcinoma. In the Triton-soluble fraction, no tyrosine-
phosphorylated  b-catenin was observed in any of the tissue
specimens. However, tyrosine-phosphorylation of p120CAS was
similarly noted in the Triton-soluble fraction of all tissue speci-
mens.
DISCUSSION
Cell adhesive properties mediated by E-cadherin are regulated by
cytoplasmic molecules including catenins, p120CAS, and
IQGAP1, as well as by small GTPases, such as Rac1, Cdc42, or
Rho (Braga et al, 1997; Kuroda et al, 1997; Takaishi et al, 1997;
Jou and Nelson 1998). Regarding E-cadherin and its associated
cytoplasmic molecules, adhesiveness at cell adhesion sites is
enhanced, when E-cadherin links to a-catenin (Nagafuchi et al,
Tyr-P.P. of
b-Catenin (I)
b-Catenin (I)
Tyr-P.P. of
p120CAS (I)
92 KDa
92 KDa
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N G1 G3
13 4 21 3 4 21 3 4 2 55
p120CAS (I)
Figure 5 Tyrosine phosphorylation of b-catenin and p120CAS in the
triton-insoluble fraction (I) extracted from normal endometrium (N),
well differentiated adenocarcinomas (G1), and poorly differentiated
adenocarcinomas (G3). Tyrosine-phosphorylation of b-catenin (Tyr-P. P.
of b-catenin) and p120CAS (Tyr-P. P of p120CAS) in the triton-insoluble
fraction (I) was examined in normal endometrium, well differentiated
adenocarcinomas, and poorly differentiated adenocarcinomas. Each
immunoblot was re-analysed using appropriate antibodies. Proteins were
extracted independently, at least twice. Immunoprecipitation and
immunoblotting were done for each extracted protein, and the results
were reproducible
Table 3 Expression and protein modification of e-cadherin and its
cytoplasmic molecules in Triton-Insoluble Fraction and Triton-Soluble
Fraction among normal endometrium and endometrial cancers
The number of positive bands in Triton-insoluble fraction
The number of positive bands in Triton-soluble fraction
N (N = 4) GI (N = 20) G3 (N = 10)
E-cadherin 4/4 5/20 10/10
a-catenin 4/4 0/20 10/10
b-catenin 4/4 3/20 9/10
g-catenin 4/4 4/20 10/10
p120CAS 4/4 4/20 10/10
IQGAP1 4/4 0/20 10/10
*b-catenin 4/0 4/0 10/0
*p120CAS 4/4 17/20 9/10
*b-catenin and *p120CAS indicate tyrosine-phosphorylated b-catenin and
p120CAS, respectively. N: Normal endometrium, G1: Well differentiated
adenocarcinomas, G3: Poorly differentiated adenocarcinomas.1991; Shimoyama et al, 1992; Ozawa and Kemler 1998).
Abnormal protein modification such as tyrosine-phosphorylation
of b-catenin or p120CAS induces a loss of cell adhesion medi-
ated by E-cadherin (Matsuyoshi et al, 1992; Behrens et al, 1993;
Kinch et al, 1995). On the other hand, IQGAP1 mediates the
dissociation between E-cadherin and a-catenin (Kuroda et al,
1998). In human cancers, this loss of E-cadherin function has
been reported to involve several different mechanisms: the
down-regulation of E-cadherin expression and gene mutation,
abnormality or deletion of catenins including the absence of 
a-catenin, and abnormal biochemical modification of cytoplas-
mic molecules such as tyrosine-phosphorylation of b-catenin or
p120CAS (Vleminckx et al, 1991; Takeich,i 1993; Mareel et al,
1994; Kinch et al, 1995; Shiozaki et al, 1996; Hirohashi, 1998).
However, little is known about changes in the localization,
expression, or protein modification of E-cadherin and its associ-
ated cytoplasmic molecules in epithelial cancers with different
degrees of differentiation.
Our evidence obtained in the present study shows that in the
normal endometrium, the zonula adherens junctions seem to be
maintained by the accumulation of E-cadherin and its associated
cytoplasmic molecules including a-catenin, b-catenin, g-catenin,
p120CAS, and IQGAP1, at cell adhesive sites. In well differenti-
ated adenocarcinomas, the complete loss of a-catenin and
IQGAP1, the decrease in expression of E-cadherin, b-catenin,
g-catenin, and p120CAS, and the reduction of tyrosine-
phosphorylation of b-catenin at cell adhesive sites were found,
compared with findings in normal endometrium, although E-
cadherin and its associated cytoplasmic molecules were expressed
in Triton-soluble fraction. Taken together, these results suggest
that the decrease of E-cadherin and loss of a-catenin at cell adhe-
sivesites may induce impairment of cell adhesiveness mediated
by E-cadherin in well differentiated adenocarcinomas. Since the
binding of IQGAP1 to E-cadherin induces a dissociation of cell
adhesive sites, the disappearance of IQGAP1 on zonula adherens
junctions might compensate for the impairment of the E-cadherin
function. Tyrosine-phosphorylation of b-catenin may contribute to
the maintenance of E-cadherin function because b-catenin at cell
boundaries was tyrosine-phosphorylated in normal endometrium.
However, it remains to be elucidated as to whether or not the
decrease of tyrosine-phosphorylation of b-catenin has any effect
on E-cadherin function.
In some cancers including gastric and colorectal cancer, no
significant correlation was observed between E-cadherin expres-
sion and distant metastasis (Kinesella et al, 1992; Oka et al,
1992; Dorudi et al, 1993; Mayer et al, 1993). Oka et al reported
that the majority of primary tumours and all tumours in live
metastatic sites of gastric cancer expressed the E-cadherin
protein (Oka et al, 1992). Previous studies suggested the possi-
bility that tumour cells express immunoreactive E-cadherin that
does not function normally (Oka et al, 1992; Becker et al, 1994;
Matsui et al, 1994). In poorly differentiated adenocarcinoma, the
abnormal complexes such as E-cadherin and IQGAP1 or E-
cadherin and other cytoplasmic molecules were formed at
different cell adhesive sites, and the strong tyrosine phosphoryla-
tion of b-catenin in Triton-insoluble fraction was observed.
These results suggest that E-cadherin might fail to function
because of a complete disruption to the cytoplasmic machinery
even though E-cadherin was distinctly expressed at cell adhesive
sites. On the other hand, the following things are also speculated
by our findings: in some cancer cells from tissues with poorly
differentiated adenocarcinomas, the aggressive accumulation of
IQGAP1 bound to E-cadherin may induce the disappearance of
catenins and p120CAS from the cell adhesive sites and may
mediate the dissociation of E-cadherin at the zonula adherens. In
other cancer cells, the loss of IQGAP1 at cell adhesive sites may
induce the tight binding of the catenins and p120CAS to E-
cadherin, and may enhance the function of E-cadherin at the
zonula adherens. In poorly differentiated adenocarcinomas, these
phenomena would happen repeatedly within the cells, as well as
in the tissues. In addition, the tyrosine-phosphorylation of b-
catenin seemed to increase in poorly differentiated adenocarci-
nomas, compared with that of normal endometrium. As a result,
it is possible that tyrosine-phosphorylation of b-catenin at cell
adhesive sites contributes to the impairment of E-cadherin func-
tion. Thus, E-cadherin function might be impaired by completely
deviating from normal cytoplasmic machinery. However, the
molecular mechanism as well as the biological meaning of our
findings remains unclear.
The tyrosine-phosphorylation of P120CAS had little influence
on the development of endometrial cancers because there was no
significant difference in the tyrosine-phosphorylation of P120CAS
among patients with normal endometrium, well, and poorly differ-
entiated adenocarcinomas. In endometrial cancer, the mutated
protein of b-catenin is localized within the cells, in the nucleus as
well as the cytoplasm (Kobayashi et al, 1999). In our study,
immunofluorescent signals for b-catenin were partly detected in
the cytoplasm as a diffuse distribution. However, a distinct accu-
mulation of b-catenin only in the nucleus was not observed in the
tissue samples. It is speculated that the mutation of b-catenin could
be detected in some cases, which had a diffuse distribution of
b-catenin in the cytoplasm.
The adhesive function mediated by E-cadherin is regulated by
E-cadherin and its associated cytoplasmic molecules, including
a-catenin, b-catenin, g-catenin, p120CAS, IQGAP1, and by small
GTPases, and is possibly associated with such tumour suppressor
genes as APC and DCC or other unknown molecules (Gumbiger
1996; Braga et al, 1997; Kuroda et al, 1997; Morin et al, 1997;
Ribinfeld et al, 1997; Takaishi et al, 1997; Jou and Nelson 1998).
In this study, we showed that each change in cytoplasmic molecule
bound to E-cadherin may be involved in endometrial cancers with
varying degrees of differentiation, which are also thought to have
different tumour characteristics. Therefore, an impairment of E-
cadherin function in epithelial cancers may be induced by a variety
of molecular mechanisms.
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